Oklahoma Cannabis Sales

Among emerging-tier markets, Oklahoma stands out for contracting on nearly every axis, with sales down 19.4% over two years and dispensary count shrinking 12% year over year to 987 stores. What distinguishes Oklahoma from other declining markets is the sharp price rebound: average prices are up 33% year over year even as unit volume fell 35%, a sign that the market is consolidating rather than simply deteriorating. The state's medical-only status and the 2023 rejection of recreational legalization limit its ceiling relative to peers that have unlocked adult-use demand.

24-Month Trend

State	Sales	YoY
Colorado	$100-110M	6.9%
New Jersey	$100-110M	12.5%
Oklahoma	$100-110M	13.5%
Maryland	$100-110M	3.1%
Pennsylvania	$90-100M	2.3%

Benchmarking

Market ComparisonApr 2026

Among emerging-tier markets, Oklahoma stands out for contracting on nearly every axis, with sales down 19.4% over two years and dispensary count shrinking 12% year over year to 987 stores. What distinguishes Oklahoma from other declining markets is the sharp price rebound: average prices are up 33% year over year even as unit volume fell 35%, a sign that the market is consolidating rather than simply deteriorating. The state's medical-only status and the 2023 rejection of recreational legalization limit its ceiling relative to peers that have unlocked adult-use demand.

24-Month Trend

State	Sales	YoY
Colorado	$100-110M	-6.9%
New Jersey	$100-110M	+12.5%
Oklahoma	$100-110M	-13.5%
Maryland	$100-110M	+3.1%
Pennsylvania	$90-100M	-2.3%

Top performing dispensaries in Oklahoma.

Store	City	Est. Sales
#1 Smokin' Savage	Oklahoma City	$1-2.5M
#2 Kush House - Classen OKC	Oklahoma City	$1-2.5M
#3 LA 2 OK Dispensary	Oklahoma City	$1-2.5M
#4 Buzzn Cannabis Company	Broken arrow	$1-2.5M
#5 Kush House - Moore	Moore	$1-2.5M

Flower still commands over half the market at 51.7% share but slid 14.5% year over year, while concentrates suffered the steepest decline at 33.6%, shrinking to just 6.4% of sales. Pre-rolls were the lone bright spot, posting a modest 0.8% gain and holding 13.9% share as consumers gravitate toward convenience formats. Vapes held relatively steady with a 3.9% decline and 19.3% share, while edibles dropped 20.8%, suggesting price-sensitive consumers are pulling back on higher-margin categories. Brands like CURE and INJOY continue to compete for shelf space across these shifting segments.

Category	Sales	Avg Price	YoY
#1Flower	$50M+	$22.86	14.5%
#2Vapes	$15-20M	$18.82	3.9%
#3Pre-Rolls	$10-15M	$10.55	0.8%
#4Edibles	$5-10M	$14.53	20.8%
#5Concentrates	$5-10M	$19.98	33.6%
#6Accessories	$1-2.5M	$10.5	19.4%
#7Topicals	$.5M-1M	$18.85	17.1%
#8Oral	$250-500K	$16.94	20.9%
#9Home-Grow	<$250K	$26.49	24.6%
#10Cbd	<$250K	$9.11	34.4%